Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
Lei Shi(Central South University), Fenghuang Zhan(University of Applied Management Studies)
Cited by 113
Related Papers
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
|Oncotarget|2014|72
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies
|Journal of Clinical Investigation|2021|42
Nek2 Is a Novel Regulator of B Cell Development and Immunological Response
|BioMed Research International|2014|26